In Depth 3 Oct 2025
The biggest biotech funding rounds in September 2025
uniQure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025.
- Latest Posts
Podcast 3 Oct 2025
Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play
This week, we discussed funding with Gerard Caelles, Chief Business Office of Splice Bio, a company that just closed a $135 million series B round.
News and Trends 1 Oct 2025
Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector?
Merck’s decision to back out of its $1 billion expansion comes as U.K. investments in life sciences declines.
News and Trends 1 Oct 2025
Asthma study suggests lung scarring may be reversible
Find out about this new study that suggest that the lung scarring that severe asthma can cause could be reversible.
Best in Biotech 30 Sep 2025
CRISPR technology’s next wave: Ten companies to watch in 2025
Driven by CASGEVY’s success, the CRISPR field is experiencing substantial growth with a new wave of companies.
News and Trends 29 Sep 2025
First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics?
FDA approval for Stealth BioTherapeutics’ elamipretide has been a long time coming. What does this mean for other ultra-rare disease companies?
ADVERTISEMENT
ADVERTISEMENT
Destination BIOSPAIN 2025: What you need to know about Spain’s flagship event for biotech
BIOSPAIN 2025 returns to Barcelona, bringing 2,200+ biotech professionals for networking, collaborations, and industry insights.
In Depth 26 Sep 2025
Can biotechnology reduce animal testing in medicine?
Animal testing is crucial for measuring the efficacy and safety of new treatments. It is also a step that everyone would like to avoid as much as possible for economic, regulatory, and ethical reasons. But what are the alternatives, and can they really reduce the use of animals in drug development? Before drug developers let […]
Podcast 26 Sep 2025
What’s next in immunology & inflammation R&D: The trends to watch
This week’s guest is Joseph Ferner of Inpart, the author of a new R&D Trends Report on Immunology and Inflammation. Together we discussed the research landscape
News and Trends 24 Sep 2025
Resurrecting the dodo: an ethical dilemma or chance at restoring biodiversity?
Colossal Biosciences has just had a major breakthrough in its attempt to revive the dodo bird. What are the ethical concerns?
In Depth 24 Sep 2025
Eli Lilly’s strategy in motion: Beyond diabetes and obesity
Delve into a biopharma giant’s strategy, Eli Lilly. This past year, the company secured regulatory milestones and strategic deals.
Best in Biotech 23 Sep 2025
Navigating German biotech: 14 key players to know
The German biotech ecosystem is well established despite the challenges it is facing. Discover thirteen key Germany-based biotech companies.
ADVERTISEMENT
